ER+, untreated and tamoxifen-treated
A number of microarray studies have reported distinct molecular profiles of breast cancers (BC), such as basal-like, ErbB2-like, and two to three luminal-like subtypes. These ...
The hypothesis of this study was that genomic grade could aid in the task of refining ER-positive molecular subtypes. In particular, the aim of this study was to determine ...
The data set consisted of 335 early-stage BC samples; 86 of these have been previously used in another study (methods described in Sotiriou et al, with the raw data available ...
--
--
Eligible samples were selected from the GSE2990 dataset according to a positive ER status by ligand-binding assay. The cutoff value for classification as positive or negative ...
Loi, Sherene, Benjamin Haibe-Kains, Christine Desmedt, Françoise Lallemand, Andrew M. Tutt, Cheryl Gillet, Paul Ellis, et al. “Definition of Clinically Distinct Molecular ...
Sample ID | series | IMS | IBS | IDS | ICR |
---|---|---|---|---|---|
GSM151259 | GUYT | Basal | IBE | PID | ICR3 |
GSM151260 | GUYT | LumB | IBD | PID | ICR2 |
GSM151261 | GUYT | Basal | IBE | FID | ICR3 |
GSM151262 | GUYT | LumA | IBD | WID | ICR1 |
GSM151263 | GUYT | LumA | IBD | PID | ICR1 |
All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.
Sample ID | Series | IMS | IBS | IDS | ICR | Array Sample ID | Sample Title | DMFS 10Y EVENT | DMFS 10Y TIME | Disease Free Survival Event | Distant Met Free Survival Event | Age At Initial Pathologic Diagnosis | Lymph Node Status | ER Status | PR Status | Histology Differentiation Grade | Tumor Size Cm | Pathology T Stage | Disease Free Survival Days | Distant Met Free Survival Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSM151259 | GUYT |
Basal |
IBE |
PID |
ICR3 |
400004990 |
GUYT_50102 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
46 |
LN- |
ER+ |
PR+ |
NA |
3 |
T2 |
3821 |
3821 |
GSM151260 | GUYT |
LumB |
IBD |
PID |
ICR2 |
400004991 |
GUYT_50105 (HG-U133PLUS2) |
DistantMetastasis |
8.28 |
Recurred/Progressed |
DistantMetastasis |
71 |
LN+ |
ER+ |
PR+ |
NA |
2 |
T1c |
3023 |
3023 |
GSM151261 | GUYT |
Basal |
IBE |
FID |
ICR3 |
400004992 |
GUYT_50106 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
NA |
NA |
1.3 |
T1c |
6037 |
6037 |
GSM151262 | GUYT |
LumA |
IBD |
WID |
ICR1 |
400004993 |
GUYT_50107 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
57 |
LN+ |
ER+ |
PR+ |
G2 |
2 |
T1c |
4370 |
4370 |
GSM151263 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400004994 |
GUYT_50108 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
69 |
LN+ |
ER+ |
PR+ |
NA |
1.5 |
T1c |
5313 |
5313 |
GSM151264 | GUYT |
Normal |
IBE |
NA |
ICR3 |
400004995 |
GUYT_50109 (HG-U133PLUS2) |
DistantMetastasis |
8.04 |
Recurred/Progressed |
DistantMetastasis |
67 |
LN- |
ER+ |
PR- |
G1 |
2 |
T1c |
2933 |
2933 |
GSM151265 | GUYT |
LumA |
IBD |
WID |
ICR3 |
400004996 |
GUYT_50110 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
56 |
LN+ |
ER+ |
PR+ |
NA |
2.5 |
T2 |
5189 |
5189 |
GSM151266 | GUYT |
LumB |
IBD |
WID |
ICR4 |
400004997 |
GUYT_50111 (HG-U133PLUS2) |
DistantMetastasis |
4.42 |
Recurred/Progressed |
DistantMetastasis |
53 |
LN+ |
ER+ |
PR+ |
G2 |
2 |
T1c |
1612 |
1612 |
GSM151267 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400004998 |
GUYT_50112 (HG-U133PLUS2) |
DistantMetastasisFree |
3.79 |
DiseaseFree |
DistantMetastasisFree |
56 |
LN+ |
ER+ |
PR+ |
G2 |
4 |
T2 |
1384 |
1384 |
GSM151268 | GUYT |
NA |
IBE |
NA |
ICR1 |
400004999 |
GUYT_50115 (HG-U133PLUS2) |
DistantMetastasis |
2.08 |
Recurred/Progressed |
DistantMetastasis |
68 |
LN+ |
ER+ |
NA |
NA |
5.1 |
T3/T4 |
760 |
760 |
GSM151269 | GUYT |
Her2 |
IBE |
WID |
ICR3 |
400005000 |
GUYT_50116 (HG-U133PLUS2) |
DistantMetastasis |
3.11 |
Recurred/Progressed |
DistantMetastasis |
59 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
1135 |
1135 |
GSM151270 | GUYT |
ClaudinLow |
IBD |
WID |
ICR2 |
400005001 |
GUYT_50117 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
57 |
LN+ |
ER+ |
PR+ |
G2 |
3.5 |
T2 |
5956 |
5956 |
GSM151271 | GUYT |
Basal |
IBE |
FID |
ICR3 |
400005002 |
GUYT_50118 (HG-U133PLUS2) |
DistantMetastasis |
2.47 |
Recurred/Progressed |
DistantMetastasis |
61 |
LN+ |
ER+ |
PR- |
G2 |
5 |
T2 |
901 |
901 |
GSM151272 | GUYT |
Her2 |
IBD |
PID |
ICR3 |
400005003 |
GUYT_50119 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
61 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
6151 |
6151 |
GSM151273 | GUYT |
Her2 |
IBD |
FID |
ICR4 |
400005004 |
GUYT_50120 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
52 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
5967 |
5967 |
GSM151274 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400005005 |
GUYT_50122 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
63 |
LN+ |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
5737 |
5737 |
GSM151275 | GUYT |
Her2 |
IBE |
FID |
ICR4 |
400005006 |
GUYT_50124 (HG-U133PLUS2) |
DistantMetastasis |
4.85 |
Recurred/Progressed |
DistantMetastasis |
62 |
LN+ |
ER+ |
PR+ |
G2 |
3.9 |
T2 |
1770 |
1770 |
GSM151276 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005007 |
GUYT_50125 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
PR+ |
G1 |
2.5 |
T2 |
5820 |
5820 |
GSM151277 | GUYT |
LumB |
IBE |
FID |
ICR4 |
400005008 |
GUYT_50126 (HG-U133PLUS2) |
DistantMetastasis |
3.54 |
Recurred/Progressed |
DistantMetastasis |
55 |
LN+ |
ER+ |
PR- |
G2 |
3 |
T2 |
1293 |
1293 |
GSM151278 | GUYT |
Normal |
IBE |
NA |
ICR3 |
400005009 |
GUYT_50128 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
60 |
LN+ |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
5959 |
5959 |
GSM151279 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005010 |
GUYT_50130 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
58 |
LN+ |
ER+ |
PR+ |
NA |
3.5 |
T2 |
3685 |
3685 |
GSM151280 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005011 |
GUYT_50131 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
60 |
LN+ |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
5725 |
5725 |
GSM151281 | GUYT |
LumB |
IBE |
PID |
ICR3 |
400005012 |
GUYT_50132 (HG-U133PLUS2) |
DistantMetastasis |
7.18 |
Recurred/Progressed |
DistantMetastasis |
66 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
2622 |
2622 |
GSM151282 | GUYT |
Her2 |
IBE |
WID |
ICR4 |
400005013 |
GUYT_50134 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
51 |
LN+ |
ER+ |
PR+ |
G3 |
3.5 |
T2 |
5554 |
5554 |
GSM151283 | GUYT |
LumA |
IBD |
PID |
ICR2 |
400005014 |
GUYT_50135 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
62 |
LN- |
ER+ |
PR- |
NA |
3 |
T2 |
5527 |
5527 |
GSM151284 | GUYT |
LumB |
IBD |
PID |
ICR1 |
400005015 |
GUYT_50136 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN+ |
ER+ |
PR- |
G2 |
2 |
T1c |
5593 |
5593 |
GSM151285 | GUYT |
LumB |
IBE |
WID |
ICR2 |
400005016 |
GUYT_50137 (HG-U133PLUS2) |
DistantMetastasis |
9.19 |
Recurred/Progressed |
DistantMetastasis |
62 |
LN+ |
ER+ |
PR+ |
NA |
2 |
T1c |
3355 |
3355 |
GSM151286 | GUYT |
LumB |
IBE |
PID |
ICR1 |
400005017 |
GUYT_50138 (HG-U133PLUS2) |
DistantMetastasis |
2.93 |
Recurred/Progressed |
DistantMetastasis |
61 |
LN- |
ER+ |
PR+ |
G3 |
2.7 |
T2 |
1070 |
1070 |
GSM151287 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400005018 |
GUYT_50143 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
59 |
LN+ |
ER+ |
PR- |
G3 |
2 |
T1c |
5518 |
5518 |
GSM151288 | GUYT |
Her2 |
IBE |
FID |
ICR3 |
400005019 |
GUYT_50146 (HG-U133PLUS2) |
DistantMetastasisFree |
7.08 |
DiseaseFree |
DistantMetastasisFree |
61 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
2585 |
2585 |
GSM151289 | GUYT |
LumB |
IBE |
FID |
ICR4 |
400005020 |
GUYT_50148 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
62 |
LN+ |
ER+ |
PR+ |
G2 |
3 |
T2 |
5189 |
5189 |
GSM151290 | GUYT |
Normal |
IBE |
NA |
ICR3 |
400005021 |
GUYT_50149 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
43 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
4462 |
4462 |
GSM151291 | GUYT |
Normal |
IBE |
NA |
ICR3 |
400005022 |
GUYT_50150 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
56 |
LN- |
ER+ |
PR- |
G2 |
2 |
T1c |
4774 |
4774 |
GSM151292 | GUYT |
LumA |
IBD |
WID |
ICR2 |
400005023 |
GUYT_50151 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN- |
ER+ |
PR+ |
NA |
4 |
T2 |
5132 |
5132 |
GSM151293 | GUYT |
LumA |
IBD |
WID |
ICR2 |
400005024 |
GUYT_50153 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
59 |
LN+ |
ER+ |
PR+ |
NA |
1.1 |
T1c |
5274 |
5274 |
GSM151294 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005025 |
GUYT_50154 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
PR+ |
G1 |
3 |
T2 |
5311 |
5311 |
GSM151295 | GUYT |
Her2 |
IBE |
FID |
ICR4 |
400005026 |
GUYT_50155 (HG-U133PLUS2) |
DistantMetastasis |
0.52 |
Recurred/Progressed |
DistantMetastasis |
53 |
LN+ |
ER+ |
PR- |
NA |
5 |
T2 |
188 |
188 |
GSM151296 | GUYT |
Basal |
IBE |
PID |
ICR2 |
400005027 |
GUYT_50156 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
66 |
LN+ |
ER+ |
PR+ |
G1 |
2.5 |
T2 |
4756 |
4756 |
GSM151297 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400005028 |
GUYT_50158 (HG-U133PLUS2) |
DistantMetastasisFree |
3.4 |
DiseaseFree |
DistantMetastasisFree |
67 |
LN+ |
ER+ |
PR- |
G3 |
1.5 |
T1c |
1242 |
1242 |
GSM151298 | GUYT |
Her2 |
IBE |
FID |
ICR4 |
400005029 |
GUYT_50159 (HG-U133PLUS2) |
DistantMetastasis |
5.27 |
Recurred/Progressed |
DistantMetastasis |
63 |
LN+ |
ER+ |
PR- |
G3 |
3 |
T2 |
1923 |
1923 |
GSM151299 | GUYT |
Basal |
IBE |
PID |
ICR2 |
400005030 |
GUYT_50160 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
61 |
LN+ |
ER+ |
PR+ |
NA |
1.5 |
T1c |
4465 |
4465 |
GSM151300 | GUYT |
Basal |
IBE |
PID |
ICR1 |
400005031 |
GUYT_50162 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
66 |
LN- |
ER+ |
PR+ |
G2 |
2 |
T1c |
5214 |
5214 |
GSM151301 | GUYT |
Basal |
IBE |
WID |
ICR3 |
400005032 |
GUYT_50163 (HG-U133PLUS2) |
DistantMetastasis |
1.17 |
Recurred/Progressed |
DistantMetastasis |
61 |
LN+ |
ER+ |
PR- |
G2 |
1.4 |
T1c |
428 |
428 |
GSM151302 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400005033 |
GUYT_50166 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
57 |
LN- |
ER+ |
PR+ |
NA |
3 |
T2 |
4797 |
4797 |
GSM151303 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005034 |
GUYT_50168 (HG-U133PLUS2) |
DistantMetastasis |
3.39 |
Recurred/Progressed |
DistantMetastasis |
59 |
LN- |
ER+ |
PR+ |
G2 |
3.8 |
T2 |
1237 |
1237 |
GSM151304 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005035 |
GUYT_50169 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
56 |
LN+ |
ER+ |
PR+ |
G2 |
3 |
T2 |
4852 |
4852 |
GSM151305 | GUYT |
LumA |
IBD |
WID |
ICR2 |
400005036 |
GUYT_50172 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
61 |
LN+ |
ER+ |
PR+ |
G1 |
2 |
T1c |
5189 |
5189 |
GSM151306 | GUYT |
Basal |
IBE |
WID |
ICR2 |
400005037 |
GUYT_50173 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
67 |
LN- |
ER+ |
PR+ |
G1 |
1.9 |
T1c |
5054 |
5054 |
GSM151307 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005038 |
GUYT_50174 (HG-U133PLUS2) |
DistantMetastasisFree |
1.04 |
DiseaseFree |
DistantMetastasisFree |
68 |
LN+ |
ER+ |
PR+ |
NA |
3 |
T2 |
378 |
378 |
GSM151308 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005039 |
GUYT_50176 (HG-U133PLUS2) |
DistantMetastasis |
2.54 |
Recurred/Progressed |
DistantMetastasis |
59 |
LN+ |
ER+ |
PR+ |
G2 |
4 |
T2 |
927 |
927 |
GSM151309 | GUYT |
Basal |
IBE |
FID |
ICR4 |
400005040 |
GUYT_50177 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
50 |
LN+ |
ER+ |
PR+ |
G3 |
3 |
T2 |
4973 |
4973 |
GSM151310 | GUYT |
LumB |
IBE |
PID |
ICR1 |
400005041 |
GUYT_50178 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
63 |
LN+ |
ER+ |
PR+ |
G3 |
3 |
T2 |
3795 |
3795 |
GSM151311 | GUYT |
LumA |
IBD |
WID |
ICR2 |
400005042 |
GUYT_50179 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
50 |
LN+ |
ER+ |
PR+ |
G1 |
1.8 |
T1c |
4628 |
4628 |
GSM151312 | GUYT |
LumA |
IBD |
PID |
ICR2 |
400005043 |
GUYT_50181 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
53 |
LN- |
ER+ |
PR+ |
G1 |
1.2 |
T1c |
4816 |
4816 |
GSM151313 | GUYT |
LumB |
IBD |
WID |
ICR2 |
400005044 |
GUYT_50182 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
70 |
LN+ |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
4988 |
4988 |
GSM151314 | GUYT |
LumA |
IBD |
PID |
ICR2 |
400005045 |
GUYT_50183 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
77 |
LN+ |
ER+ |
PR+ |
G1 |
1.6 |
T1c |
4517 |
4517 |
GSM151315 | GUYT |
LumB |
IBD |
PID |
ICR2 |
400005046 |
GUYT_50184 (HG-U133PLUS2) |
DistantMetastasisFree |
9.84 |
DiseaseFree |
DistantMetastasisFree |
68 |
LN+ |
ER+ |
PR+ |
G2 |
1.9 |
T1c |
3592 |
3592 |
GSM151316 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005047 |
GUYT_50188 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
71 |
LN- |
ER+ |
PR- |
G1 |
1.5 |
T1c |
4435 |
4435 |
GSM151317 | GUYT |
LumB |
IBE |
PID |
ICR1 |
400005048 |
GUYT_50190 (HG-U133PLUS2) |
DistantMetastasisFree |
7.82 |
DiseaseFree |
DistantMetastasisFree |
72 |
LN- |
ER+ |
PR+ |
G3 |
1.2 |
T1c |
2853 |
2853 |
GSM151318 | GUYT |
Her2 |
IBE |
PID |
ICR2 |
400005049 |
GUYT_50192 (HG-U133PLUS2) |
DistantMetastasisFree |
4.65 |
DiseaseFree |
DistantMetastasisFree |
86 |
LN- |
ER+ |
PR+ |
G2 |
1.85 |
T1c |
1699 |
1699 |
GSM151319 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005050 |
GUYT_50193 (HG-U133PLUS2) |
DistantMetastasisFree |
9.81 |
DiseaseFree |
DistantMetastasisFree |
82 |
LN+ |
ER+ |
PR+ |
G1 |
1.8 |
T1c |
3579 |
3579 |
GSM151320 | GUYT |
Her2 |
IBE |
PID |
ICR1 |
400005051 |
GUYT_50200 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
82 |
LN- |
ER+ |
PR- |
G3 |
2.5 |
T2 |
4155 |
4155 |
GSM151321 | GUYT |
LumA |
IBD |
WID |
ICR3 |
400005052 |
GUYT_50204 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
78 |
LN- |
ER+ |
PR+ |
G2 |
1.7 |
T1c |
4461 |
4461 |
GSM151322 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005053 |
GUYT_50210 (HG-U133PLUS2) |
DistantMetastasis |
9.05 |
Recurred/Progressed |
DistantMetastasis |
65 |
LN+ |
ER+ |
PR+ |
NA |
3 |
T2 |
3304 |
3304 |
GSM151323 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005054 |
GUYT_50211 (HG-U133PLUS2) |
DistantMetastasis |
8.23 |
Recurred/Progressed |
DistantMetastasis |
63 |
LN- |
ER+ |
PR+ |
G2 |
1.5 |
T1c |
3004 |
3004 |
GSM151324 | GUYT |
Normal |
IBE |
NA |
ICR4 |
400005055 |
GUYT_50213 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
65 |
LN+ |
ER+ |
PR+ |
G2 |
2 |
T1c |
4428 |
4428 |
GSM151325 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005056 |
GUYT_50218 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
51 |
LN- |
ER+ |
PR+ |
G1 |
1.5 |
T1c |
4144 |
4144 |
GSM151326 | GUYT |
LumB |
IBE |
PID |
ICR3 |
400005057 |
GUYT_50219 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
65 |
LN- |
ER+ |
PR+ |
G3 |
1.7 |
T1c |
4324 |
4324 |
GSM151327 | GUYT |
LumB |
IBE |
PID |
ICR1 |
400005058 |
GUYT_50221 (HG-U133PLUS2) |
DistantMetastasisFree |
9.18 |
DiseaseFree |
DistantMetastasisFree |
73 |
LN+ |
ER+ |
PR+ |
G3 |
2.9 |
T2 |
3349 |
3349 |
GSM151328 | GUYT |
LumB |
IBE |
PID |
ICR1 |
400005059 |
GUYT_50223 (HG-U133PLUS2) |
DistantMetastasis |
3.48 |
Recurred/Progressed |
DistantMetastasis |
67 |
LN+ |
ER+ |
PR- |
G3 |
2.6 |
T2 |
1270 |
1270 |
GSM151329 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005060 |
GUYT_50225 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
58 |
LN+ |
ER+ |
PR+ |
G1 |
3.5 |
T2 |
4481 |
4481 |
GSM151330 | GUYT |
Her2 |
IBE |
FID |
ICR4 |
400005061 |
GUYT_50228 (HG-U133PLUS2) |
DistantMetastasisFree |
9.39 |
DiseaseFree |
DistantMetastasisFree |
74 |
LN+ |
ER+ |
PR+ |
G3 |
1.5 |
T1c |
3429 |
3429 |
GSM151331 | GUYT |
Normal |
IBE |
NA |
ICR3 |
400005062 |
GUYT_50230 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
64 |
LN- |
ER+ |
PR+ |
G2 |
1.3 |
T1c |
4514 |
4514 |
GSM151332 | GUYT |
LumA |
IBD |
WID |
ICR1 |
400005063 |
GUYT_50233 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
57 |
LN+ |
ER+ |
PR- |
G1 |
1.3 |
T1c |
4596 |
4596 |
GSM151333 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005064 |
GUYT_50235 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
60 |
LN+ |
ER+ |
PR+ |
G1 |
1.3 |
T1c |
4554 |
4554 |
GSM151334 | GUYT |
LumA |
IBD |
PID |
ICR2 |
400005065 |
GUYT_50236 (HG-U133PLUS2) |
DistantMetastasisFree |
6.2 |
DiseaseFree |
DistantMetastasisFree |
72 |
LN- |
ER+ |
PR+ |
G2 |
2.5 |
T2 |
2263 |
2263 |
GSM151335 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005066 |
GUYT_50237 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
79 |
LN- |
ER+ |
PR+ |
G1 |
2.7 |
T2 |
4454 |
4454 |
GSM151336 | GUYT |
Basal |
IBE |
PID |
ICR3 |
400005067 |
GUYT_50238 (HG-U133PLUS2) |
DistantMetastasis |
2.1 |
Recurred/Progressed |
DistantMetastasis |
58 |
LN- |
ER+ |
PR- |
G2 |
3.4 |
T2 |
767 |
767 |
GSM151337 | GUYT |
Normal |
IBE |
NA |
ICR2 |
400005068 |
GUYT_50239 (HG-U133PLUS2) |
DistantMetastasisFree |
4.31 |
DiseaseFree |
DistantMetastasisFree |
62 |
LN- |
ER+ |
PR+ |
NA |
1.4 |
T1c |
1574 |
1574 |
GSM151338 | GUYT |
Basal |
IBE |
PID |
ICR1 |
400005069 |
GUYT_50243 (HG-U133PLUS2) |
DistantMetastasisFree |
6.24 |
DiseaseFree |
DistantMetastasisFree |
81 |
LN- |
ER+ |
PR- |
G2 |
2 |
T1c |
2278 |
2278 |
GSM151339 | GUYT |
Normal |
IBE |
NA |
ICR1 |
400005070 |
GUYT_50246 (HG-U133PLUS2) |
DistantMetastasisFree |
7.53 |
DiseaseFree |
DistantMetastasisFree |
77 |
LN+ |
ER+ |
PR+ |
G1 |
1.5 |
T1c |
2750 |
2750 |
GSM151340 | GUYT |
Basal |
IBE |
PID |
ICR1 |
400005071 |
GUYT_50247 (HG-U133PLUS2) |
DistantMetastasis |
1.21 |
Recurred/Progressed |
DistantMetastasis |
67 |
LN- |
ER+ |
PR- |
G2 |
4 |
T2 |
443 |
443 |
GSM151341 | GUYT |
Her2 |
IBE |
FID |
ICR4 |
400005072 |
GUYT_50248 (HG-U133PLUS2) |
DistantMetastasisFree |
8.8 |
DiseaseFree |
DistantMetastasisFree |
67 |
LN+ |
ER+ |
PR- |
G3 |
7.5 |
T3/T4 |
3211 |
3211 |
GSM151342 | GUYT |
LumA |
IBD |
PID |
ICR1 |
400005073 |
GUYT_50251 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
Recurred/Progressed |
DistantMetastasis |
70 |
LN+ |
ER+ |
PR+ |
G2 |
1.6 |
T1c |
3751 |
3751 |
GSM151343 | GUYT |
Her2 |
IBE |
PID |
ICR2 |
400005074 |
GUYT_50252 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
48 |
LN- |
ER+ |
PR- |
G3 |
2.1 |
T2 |
3973 |
3973 |
GSM151344 | GUYT |
LumB |
IBE |
PID |
ICR3 |
400005075 |
GUYT_50254 (HG-U133PLUS2) |
DistantMetastasisFree |
7.18 |
DiseaseFree |
DistantMetastasisFree |
76 |
LN- |
ER+ |
PR+ |
G3 |
1.5 |
T1c |
2622 |
2622 |
GSM151345 | GUYT |
LumA |
IBD |
PID |
ICR2 |
400005076 |
GUYT_50257 (HG-U133PLUS2) |
DistantMetastasisFree |
10 |
DiseaseFree |
DistantMetastasisFree |
67 |
LN+ |
ER+ |
PR- |
G2 |
2.2 |
T2 |
4222 |
4222 |
Name | ||
---|---|---|
All Samples | Default | View |
ER Status | View | |
Histology Differentiation Grade | View | |
Immune Benefit Status | View | |
Immunological Constant of Rejection | View | |
Lymph Node Status | View | |
Molecular Subtype | View | |
Pathology T Stage | View | |
In order to make new Group Sets or change settings, please log in. |
Group Set | |
---|---|
All Samples | |
ER Status | |
Histology Differentiation Grade | |
Immune Benefit Status | |
Immunological Constant of Rejection | |
Lymph Node Status | |
Molecular Subtype | |
Pathology T Stage |